Self-assembling peptides incorporating modifications and methods of use thereof

US9481713B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9481713-B2
Application numberUS-201414263147-A
CountryUS
Kind codeB2
Filing dateApr 28, 2014
Priority dateJul 16, 2010
Publication dateNov 1, 2016
Grant dateNov 1, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a novel class of self-assembling peptides, compositions thereof, methods for the preparation thereof and methods of use thereof. The invention also encompasses methods for tissue regeneration, increasing the production of extracellular matrix proteins, and methods of treatment comprising administering self-assembling peptides.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for regenerating a dental tissue in a patient in need thereof comprising administering to the dental tissue of said patient an effective amount of a self-assembling peptide, wherein the self-assembling peptide comprises: a. a first amino acid domain that mediates self-assembly, wherein the domain comprises alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible and wherein said domain self-assembles into a macroscopic structure when present in unmodified form, wherein the first amino acid domain has the sequence VEVKVEVKV (SEQ ID NO: 2) or VEVKVEVKVEVK (SEQ ID NO: 3); and b. a second amino acid domain that does not mediate self-assembly in isolated form, wherein the second amino acid domain comprises a biologically active motif. 2. The method of claim 1 , wherein the dental tissue is periodontal ligament tissue. 3. The method of claim 1 , wherein the biologically active motif is a laminin cell adhesion motif. 4. The method of claim 1 , wherein the second amino acid domain comprises a sequence selected from the group consisting of PDGSR (SEQ ID NO: 4), YIGSR (SEQ ID NO: 5), IKVAV (SEQ ID NO: 6), LRE (SEQ ID NO: 7), RNIAEIIKDI (SEQ ID NO:8), RYVVLPR (SEQ ID NO: 9), LGTIPG (SEQ ID NO: 10), PVGLIG (SEQ ID NO: 19) and GPVGLIG (SEQ ID NO: 12). 5. The method of claim 1 , wherein the second amino acid domain comprises an RGD peptide. 6. The method of claim 1 , wherein the second amino acid domain comprises a matrix metalloproteinase cleavable substrate. 7. The method of claim 6 , wherein the second amino acid domain comprises the sequence PVGLIG (SEQ ID NO: 19). 8. A method of treating periodontal disease in a patient in need thereof comprising administering to the periodontium of said patient an effective amount of a self-assembling peptide, wherein the self-assembling peptide comprises: a. a first amino acid domain that mediates self-assembly, wherein the domain comprises alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible and wherein said domain self-assembles into a macroscopic structure when present in unmodified form, wherein the first amino acid domain has the sequence VEVKVEVKV (SEQ ID NO: 2) or VEVKVEVKVEVK (SEQ ID NO: 3); and b. a second amino acid domain that does not mediate self-assembly in isolated form, wherein the second amino acid domain comprises a biologically active motif. 9. The method of claim 8 , wherein the method further comprises administering an effective amount of a solid biomaterial. 10. The method of claim 9 , wherein the biomaterial comprises calcium, phosphorous or a combination thereof. 11. The method of claim 9 , wherein the biomaterial comprises pores having a diameter from about 100 to about 500 microns.

Assignees

Inventors

Classifications

  • characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title

  • Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title

  • having 5 to 11 amino acids · CPC title

  • Dental/periodontal tissues · CPC title

  • Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9481713B2 cover?
The invention relates to a novel class of self-assembling peptides, compositions thereof, methods for the preparation thereof and methods of use thereof. The invention also encompasses methods for tissue regeneration, increasing the production of extracellular matrix proteins, and methods of treatment comprising administering self-assembling peptides.
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification C07K14/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).